The effect of moclobemide, reversible inhibitor of monoamine oxidase-A, on the alcoholized rat brain

被引:0
|
作者
Karaöz, E [1 ]
Kanter, M
Bapçi, Z
机构
[1] Suleyman Demirel Univ, Dept Histol & Embryol, Fac Med, Isparta, Turkey
[2] Gulhane Mil Med Acad, Dept Pharmacol, Ankara, Turkey
[3] Yuzuncu Yil Univ, Fac Vet Med, Dept Histol & Embryol, TR-65080 Kampus, Van, Turkey
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
This experiment was carried out to demonstrate the effect of moclobemide on the brains of rats fed on a diet containing alcohol. Thirty male rats, 200250 g were used. Rats were fed with a diet (milk) containing ethyl alcohol (10%) in the alcohol-only treated group and were injected subcutaneously with moclobemide (30 mg/kg) in the alcohol+moclobemide treated group daily for 21 days. It is found that the serum ethanol level in the alcohol+moclobemide treated group was significantly higher than in alcohol-only treated group at the end of the experiment. Electron microscopic examination revealed more prominent neurotoxicity in the alcohol+moclobemide treated group than in alcohol-only treated group. We concluded that moclobemide decreases the elimination of ethanol. However, more studies are needed to demonstrate its mechanism.
引用
下载
收藏
页码:217 / 225
页数:9
相关论文
共 50 条
  • [41] DRUG-INTERACTIONS WITH REVERSIBLE MONOAMINE OXIDASE-A INHIBITORS
    CALLINGHAM, BA
    CLINICAL NEUROPHARMACOLOGY, 1993, 16 : S42 - S50
  • [42] The antinociceptive effect of reversible monoamine oxidase-A inhibitors in a mouse neuropathic pain model
    Villarinho, Jardel Gomes
    Pinheiro, Kelly de Vargas
    Pinheiro, Francielle de Vargas
    Oliveira, Sara Marchesan
    Machado, Pablo
    Pinto Martins, Marcos Antonio
    Bonacorso, Helio Gauze
    Zanatta, Nilo
    Fachinetto, Roselei
    Ferreira, Juliano
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 44 : 136 - 142
  • [43] THE EFFECT OF SONICATION UPON MONOAMINE OXIDASE-A AND OXIDASE-B IN THE RAT-LIVER
    FOWLER, CJ
    CALLINGHAM, BA
    OCONNOR, MDL
    MATTHEWS, EK
    BIOCHEMICAL PHARMACOLOGY, 1980, 29 (08) : 1185 - 1188
  • [44] Biochemical and pharmacologic properties of 2614W94, a reversible, competitive inhibitor of monoamine oxidase-A
    White, HL
    Scates, PW
    Harrelson, JC
    Johnson, TE
    Norton, RM
    Jones, SA
    Rigdon, GC
    Hughes, JE
    Cooper, BR
    Harfenist, M
    DRUG DEVELOPMENT RESEARCH, 1998, 45 (01) : 1 - 9
  • [45] NEUROCATIN-INDUCED INHIBITION OF MONOAMINE OXIDASE-A IN RAT-BRAIN SYNAPTOSOMES
    FERNANDEZNOVOA, L
    PASTUSZKO, A
    WILSON, DF
    BIOCHEMICAL PHARMACOLOGY, 1991, 42 (12) : 2351 - 2354
  • [46] DIFFERENTIAL CHANGES IN MONOAMINE OXIDASE-A AND B ACTIVITY IN THE AGING RAT-BRAIN
    BENEDETTI, MS
    KEANE, PE
    JOURNAL OF NEUROCHEMISTRY, 1980, 35 (05) : 1026 - 1032
  • [47] BINDING OF [H-3] BROFAROMINE TO MONOAMINE OXIDASE-A INVIVO - DISPLACEMENT BY CLORGYLINE AND MOCLOBEMIDE
    WALDMEIER, PC
    STOCKLIN, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 180 (2-3) : 297 - 304
  • [48] NEUROCHEMICAL PROFILE OF MOCLOBEMIDE, A SHORT-ACTING AND REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE TYPE-A
    DAPRADA, M
    KETTLER, R
    KELLER, HH
    BURKARD, WP
    MUGGLIMANIGLIO, D
    HAEFELY, WE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1989, 248 (01): : 400 - 414
  • [49] A REVERSIBLE MONOAMINE-OXIDASE-A INHIBITOR (MOCLOBEMIDE) FACILITATES SMOKING CESSATION AND ABSTINENCE IN HEAVY, DEPENDENT SMOKERS
    BERLIN, I
    SAID, S
    SPREUXVAROQUAUX, O
    LAUNAY, JM
    OLIVARES, R
    MILLET, V
    LECRUBIER, Y
    PUECH, AJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (04) : 444 - 452
  • [50] PRESSER EFFECT OF ORAL TYRAMINE DURING TREATMENT WITH BEFLOXATONE, A NEW REVERSIBLE MONOAMINE OXIDASE-A INHIBITOR, IN HEALTHY-SUBJECTS
    PATAT, A
    BERLIN, I
    DURRIEU, G
    ARMAND, P
    FITOUSSI, S
    MOLINIER, P
    CAILLE, P
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (06): : 633 - 643